All medicines centrally authorised in the EU (EMA)
telmisartan;hydrochlorothiazide
epoetin zeta
trastuzumab deruxtecan
nirogacestat hydrobromide
lutetium (177Lu) vipivotide tetraxetan
asciminib hydrochloride
prasterone
A/Missouri/11/2025 (H1N1)pdm09-like strain (A/Tasmania/318/2025, CVR-351);A/Darwin/1415/2025 (H3N2)-like strain (A/Tasmania/787/2025, CVR-388);B/Pennsylvania/14/2025-like strain (B/Arizona/21/2025, wild type)
cedazuridine;decitabine
Delgocitinib
denosumab
adalimumab
type A (H1N1) strain; type A (H3N2) strain; type B strain;A/Missouri/11/2025 (H1N1)pdm09-like strain (A/Missouri/11/2025, IVR-279);A/Darwin/1454/2025 (H3N2)-like strain (A/Michigan/105/2025, IVR-285);B/Tokyo/EIS13-175/2025-like strain (B/Tokyo/EIS13-175/2025, wild type)
SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion dimer produced by recombinant DNA technology
enoxaparin sodium
pneumococcal polysaccharide conjugate vaccine (adsorbed)
allogeneic umbilical cord-derived CD34- cells, non-expanded;dorocubicel
efmoroctocog alfa
belimumab
marstacimab
Page 8 of 134 • 20 of 2,678 Medicines